Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides
The Journal of Organic Chemistry · 2026
DOI: 10.1021/acs.joc.6c00433 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Organic Chemistry, 2026. Verfasst von Shio Komiya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan. Hauptthemen laut MEDLINE: Peptides, Cyclic, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Cyclic peptides containing N-alkylated amino acids represent a promising therapeutic modality, offering access to intracellular targets previously considered "undruggable" and potential for oral administration. The N-alkyl groups (e.g., N-methyl groups) play an important role in enhancing the pharmacological properties of these peptides by improving cell membrane permeability and metabolic stability; however, the efficient synthesis of N-alkyl-rich peptides has remained an underdeveloped area of research. Herein, we report two types of peptide fragment coupling reactions developed toward the realization of highly convergent synthesis of N-alkyl-rich peptides. These two reactions enable fragment coupling of diverse N-methylated substrates with exceptional resistance to epimer formation─a challenge that has proven difficult with established methods. The first reaction utilizing pivaloyl mixed anhydride under liquid-liquid biphasic conditions addresses the substrate combinations with N-methylation at the amino terminus. The second reaction utilizing 2-hydroxypyridine N-oxide (HOPO) and Oxyma or Oxyma-B addresses the substrate combinations with N-methylation at both amino and carboxyl termini. Together, these two complementary reactions represent an advancement in the synthesis of N-alkyl-rich peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan.
ORCID-Profile: Shio Komiya
Zitieren
APA
Komiya, S., Matsumoto, T., Fujii, K., Iwamura, H., & Maeda, K. (2026). Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides. The Journal of Organic Chemistry. https://doi.org/10.1021/acs.joc.6c00433
Vancouver
Komiya S, Matsumoto T, Fujii K, Iwamura H, Maeda K. Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides. The Journal of Organic Chemistry. 2026. doi:10.1021/acs.joc.6c00433
BibTeX
@article{Komiya2026,
author = {Komiya, Shio and Matsumoto, Takumi and Fujii, Kohei and Iwamura, Hiroshi and Maeda, Kenji},
title = {Development of Two Complementary Epimerization-Resistant Fragment Coupling Reactions for Highly Convergent Synthesis of N -Alkyl-Rich Peptides},
journal = {The Journal of Organic Chemistry},
year = {2026},
doi = {10.1021/acs.joc.6c00433}
}
EUVIMED